Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 184

Similar articles for PubMed (Select 19039687)

1.

Clinical contextualization and the assessment of adverse events in HBOC trials.

Greenburg AG, Pitman A, Pearce B, Kim HW.

Artif Cells Blood Substit Immobil Biotechnol. 2008;36(6):477-86. doi: 10.1080/10731190802554000. Epub 2008 Dec 9.

PMID:
19039687
2.

HBOC-201 vasoactivity in a phase III clinical trial in orthopedic surgery subjects--extrapolation of potential risk for acute trauma trials.

Freilich D, Pearce LB, Pitman A, Greenburg G, Berzins M, Bebris L, Ahlers S, McCarron R.

J Trauma. 2009 Feb;66(2):365-76. doi: 10.1097/TA.0b013e3181820d5c.

PMID:
19204509
3.
4.

HBOC-201, hemoglobin glutamer-250 (bovine), Hemopure (Biopure Corporation).

Jahr JS, Moallempour M, Lim JC.

Expert Opin Biol Ther. 2008 Sep;8(9):1425-33. doi: 10.1517/14712598.8.9.1425 . Review.

PMID:
18694360
5.

Artificial oxygen carriers as red blood cell substitutes: a selected review and current status.

Kim HW, Greenburg AG.

Artif Organs. 2004 Sep;28(9):813-28. Review.

PMID:
15320945
6.

HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery.

Jahr JS, Mackenzie C, Pearce LB, Pitman A, Greenburg AG.

J Trauma. 2008 Jun;64(6):1484-97. doi: 10.1097/TA.0b013e318173a93f.

PMID:
18545113
7.

Blood substitutes as pharmacotherapies in clinical practice.

Jahr JS, Walker V, Manoochehri K.

Curr Opin Anaesthesiol. 2007 Aug;20(4):325-30. Review.

PMID:
17620840
8.

Toxicities of hemoglobin solutions: in search of in-vitro and in-vivo model systems.

Buehler PW, Alayash AI.

Transfusion. 2004 Oct;44(10):1516-30. Review.

PMID:
15383027
9.

Use of a hemoglobin-based oxygen-carrying solution in cats: 72 cases (1998-2000).

Gibson GR, Callan MB, Hoffman V, Giger U.

J Am Vet Med Assoc. 2002 Jul 1;221(1):96-102.

PMID:
12420832
10.

[Hemoglobin-based oxygen carriers and trials to substitute red blood cells].

Smani Y, Labrude P, Vigneron C, Faivre B.

Transfus Clin Biol. 2007 Nov;14(5):464-73. doi: 10.1016/j.tracli.2007.12.007. Epub 2008 Mar 4. Review. French.

PMID:
18295525
11.

A multicenter clinical study of the safety and activity of maleimide-polyethylene glycol-modified Hemoglobin (Hemospan) in patients undergoing major orthopedic surgery.

Olofsson C, Ahl T, Johansson T, Larsson S, NellgÄrd P, Ponzer S, Fagrell B, Przybelski R, Keipert P, Winslow N, Winslow RM.

Anesthesiology. 2006 Dec;105(6):1153-63.

PMID:
17122578
12.

Oxygen carriers ("blood substitutes").

Topfer LA, Hailey D.

Issues Emerg Health Technol. 2001 Jul;(21):1-6.

PMID:
11776287
13.

Hemoglobin-based oxygen carriers: development and clinical potential.

Ketcham EM, Cairns CB.

Ann Emerg Med. 1999 Mar;33(3):326-37. Review.

PMID:
10036348
15.

A review of blood substitutes: examining the history, clinical trial results, and ethics of hemoglobin-based oxygen carriers.

Chen JY, Scerbo M, Kramer G.

Clinics (Sao Paulo). 2009;64(8):803-13. doi: 10.1590/S1807-59322009000800016. Review.

16.

Design, operation, and interpretation of clinical trials.

Pihlstrom BL, Barnett ML.

J Dent Res. 2010 Aug;89(8):759-72. doi: 10.1177/0022034510374737. Epub 2010 Jun 25. Review.

PMID:
20581353
17.

Hemoglobin-based oxygen carriers: compassionate use and compassionate clinical trials.

Weiskopf RB.

Anesth Analg. 2010 Mar 1;110(3):659-62. doi: 10.1213/ANE.0b013e3181c85255. No abstract available.

PMID:
20185643
18.

Recent developments in hemoglobin-based oxygen carriers--an update on clinical trials.

Carmichael FJ.

Transfus Apher Sci. 2001 Feb;24(1):17-21. Review.

PMID:
11515606
19.

[Blood substitutes: state of the art and technical setbacks and why we are still disappointed].

Vigneron C, Smani Y, Faivre B.

Bull Acad Natl Med. 2007 Apr-May;191(4-5):837-47; discussion 847. Review. French.

PMID:
18225438
20.

Artificial oxygen carriers: a current review.

Henkel-Honke T, Oleck M.

AANA J. 2007 Jun;75(3):205-11. Review.

PMID:
17591302
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk